ELINS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 152,444 | 316,256 | 834,622 | 1,950,092 | 2,087,660 | 4,024,236 | 3,466,287 | 4,012,142 |
| Profit before tax | 25,286 | 52,494 | 300,974 | 777,464 | 776,011 | 1,281,142 | 1,277,221 | 1,395,306 |
| Net profit | 21,150 | 43,766 | 255,827 | 660,845 | 659,672 | 1,089,066 | 1,085,622 | 1,171,591 |
| Equity | 39,307 | 62,073 | 271,755 | 676,773 | 675,600 | 1,104,994 | 1,101,550 | 2,273,141 |
| Liabilities | 46,496 | 28,430 | 93,174 | 109,436 | 141,142 | 1,070,270 | 700,148 | 169,991 |
| Non-current assets | 1,129 | 745 | 360 | 21 | 3,868 | 4,029 | 828,102 | 909,631 |
| Current assets | 84,632 | 89,716 | 364,081 | 786,188 | 812,400 | 2,170,809 | 972,843 | 1,533,229 |
| Total assets | 85,761 | 90,461 | 364,441 | 786,209 | 816,268 | 2,174,838 | 1,800,945 | 2,442,860 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 424,610 | 742,200 | 283,866 |
| Social insurance contributions | - | - | - | - | - | 16,653 | 17,724 | 17,727 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -31.3% | +107.5% | +163.9% | +133.6% | +7.1% | +92.8% | -13.9% | +15.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 24.7% | 48.4% | 70.2% | 84.1% | 80.8% | 50.1% | 60.3% | 48.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 53.8% | 70.5% | 94.1% | 97.6% | 97.6% | 98.6% | 98.6% | 51.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 13.9% | 13.8% | 30.7% | 33.9% | 31.6% | 27.1% | 31.3% | 29.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 16.6% | 16.6% | 36.1% | 39.9% | 37.2% | 31.8% | 36.8% | 34.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.2 | 0.5 | 0.3 | 0.2 | 0.2 | 1.0 | 0.6 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 114,336 | 79,064 | 208,656 | 477,577 | 410,690 | 862,330 | 866,572 | 1,003,036 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
ELINS - Social security debts
The company had no debts to Sodra
ELINS - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
ELINS, UAB (code 126002511) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €4.01M, up 15.8% year on year, and recorded net profit of €1.17M. The profit margin was 29.2%, supported by profit before tax of €1.40M. Over the last three years, revenue moved from €4.02M in 2023 to €3.47M in 2024 and then recovered to €4.01M in 2025, while net profit remained broadly stable at about €1.09M–€1.17M. The balance sheet strengthened in 2025, with total assets of €2.44M, equity of €2.27M and liabilities of €170.0K. Equity represented 93.0% of assets, and debt to equity was 0.07. Return on equity was 51.5% and return on assets 48.0%, reflecting strong profitability relative to the asset base. Revenue per employee was €1.00M, indicating high productivity.